Clin2
NCT07570121Possibly a fitRecruiting

How Caffeine Moves Through Pregnancy and to the Baby

Preterm Labor With Preterm DeliveryPremature BirthApnea of PrematurityRespiratory Distress SyndromeBronchopulmonary Dysplasia

Treatments studied

Part of Genetic & congenital, Lungs & breathing, Women’s health & pregnancy clinical trials.

This study looks at how caffeine is absorbed and transferred to a baby during pregnancy in women at risk of early delivery. Researchers hope to understand safe caffeine use in this situation and potentially help prevent complications.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
30 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are pregnant with one baby (not multiples) between 23 and 31 full weeks
  • You are at risk of delivering early and are staying in the hospital until delivery
  • You are planned to have a cesarean delivery (surgical birth)
  • You do not have high blood pressure during pregnancy or pre-eclampsia
  • You do not have known major birth defects or genetic conditions in the baby
  • You are 18 years or older

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06972849Not yet recruiting
Caffeine for very preterm babies to improve outcomes

This trial tests whether giving caffeine citrate early to very preterm babies (born before 32 weeks) can improve their breathing and overall health. It's for babies who need caffeine anyway as part of their care, and it looks at short- and long-term benefits.

NCT07274969Not yet recruiting
Caffeine for heart stability in preterm babies

This trial tests whether caffeine therapy helps keep the heart and blood pressure stable in premature babies being treated for pauses in breathing (apnea of prematurity). Doctors want to see if caffeine is safe and effective for supporting heart function in the NICU.

NCT06518603Recruiting· Phase 4
Caffeine for preventing apnea in preterm babies in Zambia

This trial tests whether giving caffeine citrate can help prevent breathing pauses (apnea) in preterm babies who are ready to stop their current caffeine treatment. It aims to see if a short course of caffeine can keep babies stable after they come off oxygen and are eating well.

Lusaka, Lusaka Province
NCT07324941Recruiting
EEG and caffeine timing in premature infants

This study uses EEG brain scans to find the best time to stop caffeine treatment in premature babies. Caffeine is given to help with breathing, and the goal is to see if brain activity can guide when to safely stop it.

Bursa
NCT06401083Recruiting· Phase 4
Extra caffeine dose before removing breathing tube in preemies

This study tests if giving an extra dose of caffeine (a medicine that helps premature babies breathe) right before removing the breathing tube can make the transition easier. It is for very premature babies who have been on a ventilator for at least two days and are ready for their first try at breathing on their own.

Budapest
NCT07779915Not yet recruiting
Micro blood sampling for caffeine in premature babies

This trial looks at using a tiny amount of blood from a heel prick or similar method to measure caffeine levels in premature babies. The goal is to make monitoring caffeine treatment easier and less stressful for newborns.

Brivé, France

Hear when a new Premature Birth trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.